Scarica l'app Stockscreener
72.60
0.76%
0.55
Dopo l'orario di chiusura:
72.85
0.25
+0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$72.05
Aprire:
$72.515
Volume 24 ore:
2.46M
Relative Volume:
1.21
Capitalizzazione di mercato:
$35.62B
Reddito:
$10.03B
Utile/perdita netta:
$1.07B
Rapporto P/E:
33.69
EPS:
2.1549
Flusso di cassa netto:
$1.39B
1 W Prestazione:
-5.49%
1M Prestazione:
-7.27%
6M Prestazione:
-18.98%
1 anno Prestazione:
-24.91%
Intervallo 1D:
$72.47
$73.12
Intervallo di 1 settimana:
$71.55
$77.00
Portata 52W:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ALC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
How Alcon Inc. stock performs in stagflationWatch List & Free Verified High Yield Trade Plans - newser.com
Vision Care: Global Market Report 2025 | Leading Vision - GlobeNewswire
Barclays Initiates Coverage on Alcon (ALC) with Equal-Weight Rat - GuruFocus
Alcon Inc. stock trend outlook and recovery pathTrade Volume Summary & Safe Entry Zone Tips - newser.com
Barclays reiterates Equalweight rating on Alcon stock, maintains $86 price target - Investing.com Australia
Is Alcon Inc. (2U3) stock inflation resilientWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com
Broadwood slams STAAR board over “carelessness” in Alcon sale defense - Investing.com
Is Alcon Now an Opportunity After 29.6% Share Price Slide in 2024? - Yahoo Finance
Alcon stock hits 52-week low at 73.17 USD By Investing.com - Investing.com Canada
Broadwood urges STAAR shareholders to reject Alcon acquisition By Investing.com - Investing.com Canada
Broadwood urges STAAR shareholders to reject Alcon acquisition - Investing.com
Alcon stock hits 52-week low at 73.17 USD - Investing.com
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener
How to integrate Alcon Inc. into portfolio analysis toolsStop Loss & Accurate Trade Setup Notifications - newser.com
Short interest data insights for Alcon Inc.Day Trade & Precise Buy Zone Tips - newser.com
Can trapped investors hope for a rebound in Alcon Inc.Bond Market & Community Verified Watchlist Alerts - newser.com
Alcon Stock Rated Buy by BTIG Following TRYPTYR Approval - MSN
What hedge fund moves indicate for Alcon Inc. Ordinary Shares stockNew Guidance & Intraday High Probability Alerts - newser.com
How to forecast Alcon Inc. trends using time seriesTrade Ideas & Daily Price Action Insights - newser.com
What to do if you’re stuck in Alcon Inc.2025 Sector Review & Daily Oversold Bounce Ideas - newser.com
STAAR Surgical Board Defends $1.5 Billion Alcon Acquisition Plan - Finimize
Glass Lewis recommends shareholders vote against STAAR-Alcon deal By Investing.com - Investing.com Nigeria
STAAR urges shareholders to approve Alcon merger despite Glass Lewis report - Investing.com Nigeria
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - MSN
Alcon (ALC) Faces Opposition in Staar Surgical Merger Deal - GuruFocus
STAAR Surgical (STAA): Proxy Adviser Urges Rejection of Alcon De - GuruFocus
STAAR urges shareholders to approve Alcon merger despite Glass Lewis report By Investing.com - Investing.com South Africa
Glass Lewis Advises Against Alcon (ALC) Acquisition of STAAR - GuruFocus
STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - Seeking Alpha
Broadwood and Glass Lewis urge Staar shareholders to vote "against" sale to Alcon - MarketScreener
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon - The Globe and Mail
Broadwood urges STAAR shareholders to reject Alcon takeover bid - Investing.com
Broadwood Partners Questions Integrity of STAAR Surgical’s Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon | FinancialContent - FinancialContent
Defender Capital Opposes STAAR Surgical's Proposed Acquisition By Alcon - Nasdaq
Defender Capital Opposes STAAR Surgical?s Sale to Alcon - MarketScreener
Alcon's Proposed Acquisition of STAAR Faces Shareholder Oppositi - GuruFocus
Warner Bros. Challenges Alcon Bid for ‘Matrix’ Studio Rights - Bloomberg Law News
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon - Stock Titan
Yunqi Capital, One Of Staar Surgical Company’S Largest Shareholders, Reiterates Its Opposition To The Proposed Merger With Alcon - TradingView
Yunqi Capital opposes sale of STAAR Surgical to Alcon - Investing.com
Yunqi Capital opposes sale of STAAR Surgical to Alcon By Investing.com - Investing.com Nigeria
Yunqi Capital Challenges Proposed Sale of STAAR to Alcon (ALC) - GuruFocus
Yunqi Capital urges STAAR shareholders to oppose Alcon merger - TipRanks
$62/Share Offer Challenged: STAAR Shareholder Yunqi (5.1%) Reiterates Opposition Ahead of Vote - Stock Titan
Dry Eye Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AbbVie, Allergan, AFT Pharmaceuticals, Akorn, Alcon Inc., Bausch Health - Barchart.com
STAAR Surgical Faces Shareholder Clash Over Alcon Buyout - Finimize
How Alcon Inc. Ordinary Shares stock benefits from digital adoptionWeekly Profit Summary & Weekly Momentum Picks - newser.com
Broadwood urges STAAR shareholders to reject $28 per share Alcon deal - Investing.com
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon - Stock Titan
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
3.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):